Foreword
The ASH Annual Meeting is the world's largest and most comprehensive international event covering malignant and non-malignant hematology, attracting more than 25,000 hematologists and other related healthcare professionals from more than 100 countries around the world each year.
In order to keep the majority of hematologists abreast of the latest developments of this ASH annual meeting and share new views in the field of international hematology, we are invitedProfessor Wu Tong, Director of the Department of Hematopoietic Stem Cell Transplantation and Medical Dean of Beijing Gaobo Boren Hospital, Beijing Research Center of Global Medicine (Hematology).Let's talk about a new strategy for CD7 CAR-T bridging transplantation **T-ALL.
Expert presentation
Prof. Tong Wu
Global Medical (Hematology) Beijing Research Center, Beijing Gaobo Boren Hospital.
Director of the Department of Hematopoietic Stem Cell Transplantation and Medical Director of Beijing Gaobo Boren Hospital, Beijing Research Center of Global Medicine (Hematology).
Member of the Academic Committee of the Asia-Pacific Society for Bone Marrow Transplantation (APBMT).
He is a member of the Standing Committee of the Hematology and Oncology Committee of the Chinese Anti-Cancer Association and the deputy head of the hematopoietic stem cell transplantation and cell group.
Chairman of the Digital Diagnosis and Treatment Committee for Hematological Diseases.
Vice Chairman of the Targeted Professional Committee of the Association of Women Physicians.
Vice Chairman of the Hematology Institution Branch of the Chinese Hospital Association.
He is a member of the editorial board of Chinese Journal of Hematology, Hematology Oncology and Stem Cell Therapy and Blood Chinese, and the executive editor of Hematology and Oncology Discovery.
Original link |
Contents** Bo Medical Oncologists
Audit |Fang Yueli, Jia Dongxue.